2021
DOI: 10.1155/2021/5556784
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Infliximab- (IFX-) Responsive Blood Signatures for the Treatment of Rheumatoid Arthritis

Abstract: Rheumatoid arthritis (RA) is a severe chronic pathogenic inflammatory abnormality that damages small joints. Comprehensive diagnosis and treatment procedures for RA have been established because of its severe symptoms and relatively high morbidity. Medication and surgery are the two major therapeutic approaches. Infliximab (IFX) is a novel biological agent applied for the treatment of RA. IFX improves physical functions and benefits the achievement of clinical remission even under discontinuous medication. How… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 94 publications
0
2
0
Order By: Relevance
“…We boldly speculated that the USP16 and UHMK1 may influence LEF response in RA patients via the metabolic network. DISC1 , which encodes a scaffold protein, promotes hemoglobin synthesis in the peripheral blood ( 59 ). Several studies assessed the DISC1 contents in PBMCs of BD patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We boldly speculated that the USP16 and UHMK1 may influence LEF response in RA patients via the metabolic network. DISC1 , which encodes a scaffold protein, promotes hemoglobin synthesis in the peripheral blood ( 59 ). Several studies assessed the DISC1 contents in PBMCs of BD patients.…”
Section: Discussionmentioning
confidence: 99%
“…(A) simple model (B) complex model. encodes a scaffold protein, promotes hemoglobin synthesis in the peripheral blood (59). Several studies assessed the DISC1 contents in PBMCs of BD patients.…”
Section: B Amentioning
confidence: 99%